ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 272 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,677 | -59.9% | 62,425 | -46.8% | 0.08% | -56.6% |
| Q2 2023 | $4,183 | +698.3% | 117,295 | +468.8% | 0.18% | +628.0% |
| Q1 2023 | $524 | -100.0% | 20,620 | -72.7% | 0.02% | -83.4% |
| Q3 2022 | $2,494,000 | +16.7% | 75,462 | +24.3% | 0.15% | -6.2% |
| Q2 2022 | $2,138,000 | +36.1% | 60,719 | +77.7% | 0.16% | +56.3% |
| Q1 2022 | $1,571,000 | +93.5% | 34,165 | +178.8% | 0.10% | +2.0% |
| Q4 2021 | $812,000 | -12.3% | 12,254 | -17.3% | 0.10% | -17.9% |
| Q3 2021 | $926,000 | – | 14,826 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |